Asthma exacerbation after administration of nicotine nasal spray for smoking cessation.

Journal Article

A 58-year-old man experienced an asthma exacerbation after administration of nicotine nasal spray for smoking cessation. His medical history was significant for asthma, chronic obstructive pulmonary disease, hypertension, and tobacco use when he was prescribed nicotine nasal spray for smoking cessation in an outpatient setting. Within the first 3 days of administering the spray, he developed wheezing, coughing, and significant shortness of breath, which required hospitalization. The patient was hospitalized for 48 hours and discharged with a diagnosis of asthma exacerbation probably related to administration of nicotine nasal spray. Prudent administration of nicotine nasal spray is recommended in patients with underlying respiratory disease. Patients should be counseled on the potential adverse effects of treatment and proper administration techniques in order to minimize these effects.

Full Text

Duke Authors

Cited Authors

  • Roth, MT; Westman, EC

Published Date

  • June 2002

Published In

Volume / Issue

  • 22 / 6

Start / End Page

  • 779 - 782

PubMed ID

  • 12066970

International Standard Serial Number (ISSN)

  • 0277-0008

Language

  • eng

Conference Location

  • United States